Reaction
Rectal Polyp reporting signals
As of the last recalculation, Rectal Polyp appears in 986 FAERS reports alongside 12 co-occurring drug terms. The strongest observed disproportionality signal is OLMESARTAN MEDOXOMIL (PRR 87.8).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Olmesartan Medoxomil | 130 | 87.8 | 88.1 |
| Isotretinoin | 129 | 63.2 | 63.4 |
| Indapamide | 36 | 44.0 | 44.1 |
| Nitrofurantoin | 33 | 43.7 | 43.8 |
| Nitrofurantoin (Monohydrate/Macrocrystals) | 33 | 43.1 | 43.2 |
| Acetaminophen And Codeine | 23 | 40.8 | 40.9 |
| Octreotide Acetate | 40 | 28.7 | 28.7 |
| Temazepam | 38 | 22.1 | 22.1 |
| Teduglutide | 8 | 12.6 | 12.6 |
| Dabrafenib | 8 | 8.1 | 8.1 |
| Diclofenac Potassium, Film Coated | 3 | 7.5 | 7.5 |
| Diclofenac Potassium Tablets | 3 | 7.5 | 7.5 |